InvestorsHub Logo

trader59

12/08/21 9:35 PM

#11891 RE: the_hoard #11889

Because that source has it wrong, dead wrong.

Google is always a friend:

https://www.biospace.com/article/releases/immune-pharma-signs-letter-of-intent-with-b-pint-pharma-b-regarding-license-and-commercializion-of-ceplene-in-latin-america-/

The tip was the 2017 in the link you’ve posted. That deal happened 2 years before the bankruptcy. It is likely the licensing deal passed on to the new owners of Ceplene.

Save some time, just Google up what Chapter 7 is, and you’ll find there is zero “hope” for Immune and its shareholders.